CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (AMEX: IDP) today announced that Robert Karr, M.D., President of Idera, will discuss the Company’s Toll-Like Receptor - targeted drug discovery and development programs and provide a general corporate overview at the Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference taking place May 14-15, 2007, in Monte Carlo, Monaco. The presentation will begin at 2:35 p.m. GMT + 1 (8:35 a.m. EDT) on Monday, May 14, 2007.
